S(+)-Ibuprofen Effects on Asprin Treated Volunteers

Gebro Pharma

Status and phase: Completed; Phase 1

Conditions: Drug Interactions

Treatments: Drug: S(+)-ibuprofen

Study type: Interventional

Funder types: Industry

Identifiers

NCT00442585

EUDRACT 2006-002159-33

Gebro-I-24-13

Details and patient eligibility

About

The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy caucasian volunteer
• Must be able to swallow tablets

Exclusion criteria

• Underlying diseases
• Ulcus pepticum in history
• Abuse of alcoholic beverages (40g/d)
• Hypersensitivity to investigational medicinal products

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind